Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 20

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 20
---
ating Committee monitors the effectiveness of our corporate governance guidelines. The Compensation Committee of the Board (the “Compensation Committee”) assesses and monitors our practices and policies of employee compensation as they relate to risk management and risk-taking incentives. Meetings of the Board of Directors The Board met five times during 2024. Each Board member attended at least 75% of the aggregate number of meetings of the Board and of the committees on which they served, held during the portion of 2024 for which they were directors or committee members, respectively. As required under applicable Nasdaq listing rules, in 2024, the Company’s independent directors met five times in regularly scheduled executive sessions at which only independent directors were present. Under our Corporate Governance Guidelines, directors are encouraged, but not required, to attend the Company’s annual stockholders meetings. Five of the eight then-serving directors attended the 2024 Annual Meeting. 11

TABLE OF CONTENTS

Information Regarding Committees of the Board of Directors The Board has three standing committees: the Audit Committee, Compensation Committee, and Nominating Committee. The table below provides membership and meeting information for the fiscal year ended December 31, 2024 for each of the Board committees. Dr Fordyce does not serve on any of the standing committees.

| Name                       |     | Audit |     | Compensation |     | Nominating and 
      Corporate 
     Governance |
| Michael Morrissey, Ph.D.   |     |     X |     |              |     |              X |
| Andrew Cheng, M.D., Ph.D.1 |     |       |     |            X |     |              X |
| Patrick Enright            |     |       |     |           X* |     |                |
| Kimball Hall               |     |       |     |            X |     |                |
| Maha Katabi, Ph.D., C.F.A  |     |       |     |              |     |             X* |
| Scott Morrison             |     |    X* |     |              |     |                |
| Christy Oliger2            |     |       |     |              |     |              X |
| Beth Seidenberg, M.D.      |     |     X |     |              |     |                |
| Total meetings in 2024     |     |     3 |     |            4 |     |              1 |

| * | Committee Chair |

| (1) | Dr. Cheng ceased serving as a member